Chembio Diagnostics Inc (CEMI.OQ) Quote| Reuters.com
Edition:
United States

Chembio Diagnostics Inc (CEMI.OQ)

CEMI.OQ on NASDAQ Stock Exchange Capital Market

7.92USD
27 Jun 2016
Change (% chg)

-- (--)
Prev Close
$7.92
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
6,632
52-wk High
$9.32
52-wk Low
$3.33

CEMI.OQ

Chart for CEMI.OQ

About

Chembio Diagnostics, Inc. (Chembio), and its subsidiary, Chembio Diagnostic Systems, Inc., develop, manufacture, market and license rapid point-of-care diagnostic tests (POCTs) that detect infectious diseases. The Company's products available are rapid tests for the detection of human immunodeficiency virus (HIV) 1/2 antibodies,... (more)

Overall

Beta: 1.07
Market Cap(Mil.): $76.59
Shares Outstanding(Mil.): 9.67
Dividend: --
Yield (%): --

Financials

  CEMI.OQ Industry Sector
P/E (TTM): -- 32.69 34.11
EPS (TTM): -0.21 -- --
ROI: -11.22 15.00 14.23
ROE: -11.22 16.08 15.46

BRIEF-Chembio Diagnostics posts Q1 loss per share of $0.03

* Chembio Diagnostics reports first quarter 2016 financial results

May 12 2016

BRIEF-Chembio Diagnostics Bio-Manguinhos to introduce point-of-care diagnostic test for zika virus in Brazil

* Chembio and Bio-Manguinhos announce plans to introduce a point-of-care diagnostic test for zika virus in brazil

May 05 2016

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.